Brain Metastases From Esophageal Cancer: A Phenomenon of Adjuvant Therapy?

A dose-related increased incidence of brain metastases after adjuvant therapy for esophageal cancer cannot be explained by increased longevity. Adjuvant therapy itself, not just advanced disease, appears to create conditions conducive to developing these rapidly fatal metastases.